Stifel analyst Stephen Willey raised the firm’s price target on Exelixis (EXEL) to $43 from $41 and keeps a Hold rating on the shares following a Q3 earnings announcement and corporate update that the firm says had “no significant surprises.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXEL:
- Exelixis price target raised to $41 from $40 at Barclays
- Exelixis’s Strong Financial Performance and Growth Prospects Earns Buy Rating from Yaron Werber
- Exelixis Reports Strong Q3 2025 Financial Results
- Exelixis: Strong Growth Prospects and Strategic Focus Justify Buy Rating
- Exelixis Announces $750 Million Stock Repurchase Program